Acadia Pharmaceuticals (ACAD) Q2 2026 Earnings

13MayConfirmed
Q3 2025
Q4 2025
Q1 2026
Next
0.06
0.57
1.09
1.6

Details

Expected EPS
0.062301
Actual EPS
N/A
Surprise EPS
-0.06
Surprise Percent
+100%

Description

Acadia Pharmaceuticals (ACAD) will report earnings of for Q2 2026 on May 13, 2026.

0 Comments

Share your thoughts